CareDx: AI-supported Transplant Medicine Accelerates Revenue Growth to 39%!
Reading Time: 2 minutes
CareDx (CDNA) has specialized as a precision medicine company in the discovery, development, and marketing of non-invasive, molecular test solutions as well as digital health services for transplantation patients. The business model aims to support patients and doctors both before and after an organ transplant, particularly in heart, kidney, and lung transplants, with accurate genomic data. Recently, VANTx was introduced as an AI-supported data platform for transplant centers to transform complex patient data into understandable and actionable insights....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
